Medical & Healthcare apps of Chugai are listed with us

Chugai

Chugai Pharmaceutical Co., Ltd. is a subsidiary drug manufacturer operating in Japan controlled by Hoffmann–La Roche, which owns 52% of the company. Previous to Roche's takeover in 2002, Chugai was a pioneering discoverer of many important pharmaceutical compounds. Osamu Nagayama is the current representative director, chairman, and CEO and Tatsuro Kosaka is the current representative director, president, and COO.